Monte Rosa Therapeutics, Inc. (GLUE) stock forecast — our track record

Lyra published one GLUE stock forecast, and that prediction was published on January 8, 2026, before the outcome was known. It used a short term (0 to 3 months) horizon. The forecast window ended on April 8, 2026, and the call was then closed and scored. There were no medium term or long term calls for GLUE in this record.

Overall, the GLUE prediction did not reach its target, but it also was not scored as a miss. It ended as one partial result. The target was reached in none of the closed forecasts, and there were no misses. The average success score was 50%. The short-term average score was also 50%, because the single closed GLUE call used that horizon.

The best call was the January 8, 2026 forecast. It looked for 20% growth, and the stock rose as much as 3.2% during the forecast window. The target was not reached. The worst call was the same January 8, 2026 forecast, with the same 20% expected growth, 3.2% peak gain, and 50% score. The track record was limited to one closed call, and it was a partial hit rather than a reached target or a miss.